Term ends Oct 25, 2033 · Medium confidence
20-year base term ends Oct 25, 2033
Oct 25, 2013
Oct 25, 2033
Dec 6, 2016
This patent's term is its 20-year base term, with no adjustment for prosecution delay. A terminal disclaimer is resolved from the filed document, and it ends no earlier than this term, so it shortens nothing. 2 of 3 maintenance fees are paid so far. Confidence: Medium. from the record
How we calculated this date
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Oct 25, 2013, when application PCT/US2013/066783, the earliest non-provisional in its chain, was filed (this one was filed May 11, 2015); a parent in its chain could not be resolved (the next row) | Oct 25, 2033 | High confidence |
| Continuity chain | A parent in the chain could not be resolved | dated from this application's own claim | Medium confidence |
| Patent term adjustment | None on file | no change | High confidence |
| Terminal disclaimer cap | Disclaimer resolved from the filed document (refs US 8,877,197, US 8,945,562, US 9,074,003, US 9,074,004, US 9,206,259, US 9,562,092) | resolves to Oct 25, 2033, no earlier than this term, so no change | Medium confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 2 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Oct 25, 2033 | Medium confidence |
Partial family
| Application PCT/US2013/066783 | PCT application no patent term | no patent term |
| US 9,562,106 | In force Oct 2033 | Oct 2033 |
| US 9,512,233 | this patent Oct 2033 | Oct 2033 |
| US 10,457,745 | In force Oct 2033 | Oct 2033 |
| Application 16/575,265 | Abandoned not computed | not computed |
| US 12,215,169 | In force Oct 2033 | Oct 2033 |
| Application 18/989,593 | Pending not computed | not computed |
Assignments
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Jun 24, 2015 Reel 35897, frame 361 | Van Vlasselaer, Peter; Parry, Graham; Stagliano, Nancy E.; Panicker, Sandip | True North Therapeutics, Inc. | Assignment of Assignor's Interest |
| Oct 4, 2017 Reel 44126, frame 710 | True North Therapeutics, Inc. | Bioverativ USA Inc. | Change of Name |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
What's changing
A terminal disclaimer resolved from the filed document, referencing US 8,877,197, US 8,945,562, US 9,074,003, US 9,074,004, US 9,206,259, US 9,562,092, ends no earlier than this term, so it caps nothing.